A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial

For patients with coronary artery disease undergoing coronary bypass surgery, acetylsalicylic acid (ASA) currently represents the gold standard of antiplatelet treatment. However, adverse cardiovascular event rates in the first year after coronary artery bypass grafting (CABG) still exceed 10%. Graf...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2016-09, Vol.179, p.69-76
Hauptverfasser:	de Waha, Antoinette, Sandner, Sigrid, von Scheidt, Moritz, Boening, Andreas, Koch-Buettner, Katharina, Hammel, Dieter, Hambrecht, Rainer, Danner, Bernhard C, Schöndube, Friedrich A, Goerlach, Gerold, Fischlein, Theodor, Schmoeckel, Michael, Oberhoffer, Martin, Schulz, Rainer, Walther, Thomas, Ziegelhöffer, Tibor, Knosalla, Christoph, Schönrath, Felix, Beyersdorf, Friedhelm, Siepe, Matthias, Attmann, Tim, Misfeld, Martin, Mohr, Friedrich-Wilhelm, Sievers, Hans-Hinrich, Joost, Alexander, Putman, Leon M, Laufer, Günther, Hamm, Christian, Zeymer, Uwe, Kastrati, Adnan, Radke, Peter W, Lange, Rüdiger, Cremer, Jochen, Schunkert, Heribert
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine - analogs & derivatives Adenosine - therapeutic use Aged Aspirin - therapeutic use Cardiovascular Diseases - mortality Coronary Artery Bypass - methods Coronary Artery Disease - therapy Double-Blind Method Female Humans Male Middle Aged Myocardial Infarction - epidemiology Myocardial Revascularization - statistics & numerical data Platelet Aggregation Inhibitors - therapeutic use Purinergic P2Y Receptor Antagonists - therapeutic use Stroke - epidemiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!